title: Acute ST-segment elevation myocardial infarction: critical care perspective.
abstract: More than 1.2 million patients suffer from new or recurrent ischemic events occur annually. This includes an estimated 565,000 cases of first and 300,000 cases of recurrent myocardial infarction (MI). Although mortality from acute MI has declined in recent years, it still remains high at 25% to 30%. Despite its high mortality, prognosis can be improved with timely and effective use of evidence-based treatment in the acute setting. This review outlines the critical care management strategies for ST-segment MI (STEMI).
authors.affiliation: Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA.
authors.forename: Amrita M
authors.initials: AM
authors.lastname: Karve
authors.forename: Eduardo
authors.initials: E
authors.lastname: Bossone
authors.forename: Rajendra H
authors.initials: RH
authors.lastname: Mehta
mesh_terms: D000465:Algorithms; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003422:Critical Care; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D009204:Myocardial Revascularization / Q000379:methods; D011379:Prognosis; D015912:Thrombolytic Therapy
chemical_list: D002317:Cardiovascular Agents